A tumour marker. Although CA 19.9 is frequently elevated in patients with Ca pancreas and is used for monitoring therapy, it is not useful in the diagnosis of Ca pancreas.
Tube
01 (SE) – Serum Gel
ID
Tests&Tubes0027
Additional information
5% of the population cannot synthesise CA 19-9 (individuals with Lewis neg blood group antigens).
Elevations may be seen in cirrhosis and benign biliary tract disease. PLEASE NOTE: TEST CAN ONLY BE ADDED TO A SAMPLE WITHIN 8 HOURS OF COLLECTION
Turn around
A&E: N/A
Day Case: N/A
In-Patient: 48 Hours
Out-Patient: 48 Hours
GP: N/A
Send to
Blood Sciences Cross Site
Contact
For further details please contact Leeds Pathology customer services: [email protected].
Collection Con
Minimum volume – 300µl serum / plasma
Instructions for Lab Staff: Standard lab processing- No special requirements
Sample REQ
Blood
Ref. Range Notes
Units
ku/L